Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MeDSuN Voluntary Reporting Shines Light On Potential Device Concern

This article was originally published in The Gray Sheet

Executive Summary

FDA's Medical Device Surveillance Network (MeDSuN) recently alerted FDA to a problem with a certain line of angiocatheter guidewires, demonstrating the ability of the system to identify potential device concerns, staffers note

You may also be interested in...



FDA Sings Paeans To Postmarket Vigilance: “Lower Cost,” Quicker Approvals

FDA's plan to hire a new chief economist is consistent with Commissioner Mark McClellan's pledge to evaluate the agency's cost efficiency as a top priority of his tenure

FDA Sings Paeans To Postmarket Vigilance: “Lower Cost,” Quicker Approvals

FDA's plan to hire a new chief economist is consistent with Commissioner Mark McClellan's pledge to evaluate the agency's cost efficiency as a top priority of his tenure

MeDSuN Pilot Phase II Ready To Start In February; Reg Is 2-3 Years Away

FDA anticipates that beta testing of its MeDSuN Internet-based surveillance system will begin the week of Jan. 21, as software and hardware development is now complete

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel